dehydroepiandrosterone sulfate has been researched along with naloxone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mamiya, T; Nabeshima, T; Nagai, T; Noda, Y; Ren, X | 1 |
| Inder, WJ; Mulder, RT; Prickett, TC | 1 |
| Bertoni, G; Da Dalt, L; Gabai, G; Marinelli, L; Merlo, M; Trevisi, E | 1 |
3 other study(ies) available for dehydroepiandrosterone sulfate and naloxone
| Article | Year |
|---|---|
A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase.
Topics: Analysis of Variance; Animals; Behavior, Animal; Blotting, Western; Cerebral Cortex; Cyclic AMP; Dehydroepiandrosterone Sulfate; Drug Interactions; Drug Tolerance; Gene Expression Regulation; Male; Mice; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Pain Measurement; Proto-Oncogene Proteins c-fos; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substance Withdrawal Syndrome; Thalamus; Time Factors | 2004 |
Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
Topics: Adrenocorticotropic Hormone; Case-Control Studies; Corticotropin-Releasing Hormone; Dehydroepiandrosterone Sulfate; Fatigue Syndrome, Chronic; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin-Like Growth Factor I; Naloxone; Opioid Peptides; Pituitary-Adrenal System; Psychological Tests; Single-Blind Method | 2005 |
Dehydroepiandrosterone secretion in dairy cattle is episodic and unaffected by ACTH stimulation.
Topics: Adrenocorticotropic Hormone; Animals; Cattle; Data Interpretation, Statistical; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Hydrocortisone; Injections, Intramuscular; Lactation; Luteolysis; Milk Ejection; Naloxone; Narcotic Antagonists; Secretory Rate; Stimulation, Chemical; Time Factors | 2007 |